WHO unveils comprehensive strategy to combat dengue and Aedes-borne arboviruses

Share this article Lupin Vilfuro-G helps manage and treat moderate to severe COPD. Credit: Billion Photos / Shutterstock.com. Pharmaceutical company Lupin has introduced the fixed-dose

Alu­mis, an im­munol­o­gy drug de­vel­op­er on the cusp of Phase 3, will go pub­lic Fri­day in a small­er IPO than it orig­i­nal­ly pro­ject­ed. The Bay

Despite numerous challenges faced by life sciences this year, IPOs have emerged as a resilient force. Image credit: GettyImages/ Daniel Grill. When Australian biotech Telix